Medications commonly used to treat diabetes and induce weight loss may reduce the risk of cancer progressing, new research has suggested. "Our study found that use of GLP-1 drugs, compared to DPP-4 ...

There’s been a flood of research that suggests GLP-1 medications like Ozempic and Zepbound can lower your risk of developing a slew of serious illnesses or help to turn things around if you already ...

A major breast imaging study links GLP-1 agonists to lower breast cancer incidence, raising hopes for a new prevention strategy while underscoring the need for prospective clinical trials. Study: ...

GLP-1 drugs may result in better outcomes for cancer patients, a new study has claimed. While GLP-1 drugs, such as Ozempic and Wegovy, are most commonly known for their weight-loss results, they were ...

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction—and help people who already have one, a new study shows. Semaglutide (also known as Ozempic), ...

GLP-1 drugs may reduce cancer progression in patients with certain obesity-related cancers like lung, breast, colorectal and liver cancers, a new research has found Researchers analyzed over 10,000 ...